Integrum AB (publ) (STO:INTEG.B)
Sweden
· Delayed Price · Currency is SEK 8.31
+0.51 (6.54%)
Mar 9, 2026, 4:41 PM CET
Integrum AB Company Description
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses.
The company provides prostheses for the Rehabilitation of Amputees (OPRA) implant systems, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket.
The OPRA implant system offers protection to the patient by avoiding bone fractures from accidental loads.
It also provides Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation.
It sells its implant systems to hospitals, clinics, and orthopedists worldwide. The company was incorporated in 1990 and is headquartered in Mölndal, Sweden.
Integrum AB (publ)
| Country | Sweden |
| Founded | 1990 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 37 |
| CEO | Martin Hillsten |
Contact Details
Address: Gemenskapens gata 9 Mölndal, 431 53 Sweden | |
| Phone | 46 3 17 60 10 60 |
| Website | integrum.se |
Stock Details
| Ticker Symbol | INTEG.B |
| Exchange | Nasdaq Stockholm |
| Share Class | Class B Shares |
| Fiscal Year | May - April |
| Reporting Currency | SEK |
| ISIN Number | SE0009807266 |
| SIC Code | 3842 |
Key Executives
| Name | Position |
|---|---|
| Anna-Tove Branemark | Chief Executive Officer of Integrum Inc. |
| Martin Hillsten | Chief Executive Officer |
| Dr. Rickard Branemark | Founder, Owner, Chief Medical and Scientific Officer and Chairman of the Board |
| Louise Wahlin | Chief Financial Officer |